Brain Tumor 101 Series: “Temozolomide and MGMT Methylation”


BrainCancer.org presents our 5th video in the Brain Tumors 101 series, “Temozolomide and MGMT Methylation”. In this video, Dr. Charles Cobbs, Neurosurgeon and The Gregory Foltz Endowed Director of The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment explains how MGMT Methylation is impacted by the chemotherapy drug, Temozolomide. Topics covered: How is DNA impacted by MGMT Methylation and what are the statistics behind the original 2005 study that showed improved survival prognosis if glioblastoma brain tumors showed MGMT Methylation.

Leave a Reply